Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity
about
An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.Sulfoximines: a neglected opportunity in medicinal chemistry.N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.Synthesis of chiral sulfoximine-based thioureas and their application in asymmetric organocatalysis.FAK inhibitors in Cancer, a patent review.Copper-Catalyzed Direct Sulfoximination of Heteroaromatic N-Oxides by Dual C-H/N-H Dehydrogenative Cross-Coupling.Access to N-cyanosulfoximines by transition metal-free iminations of sulfoxides.Copper promoted N-alkylation of sulfoximines with alkylboronic acid under mild conditions.Protein Kinase 2β Is Expressed in Neural Crest-Derived Urinary Pacemaker Cells and Required for Pyeloureteric Contraction.Sulfur Imidations by Light-Induced Ruthenium-Catalyzed Nitrene Transfer ReactionsLight-Induced Ruthenium-Catalyzed Nitrene Transfer Reactions: A Photochemical Approach towards N-Acyl Sulfimides and SulfoximinesN-Alkylations ofNH-Sulfoximines andNH-Sulfondiimines with Alkyl Halides Mediated by Potassium Hydroxide in Dimethyl SulfoxideCopper-Catalyzed Oxidative Cross-Coupling of Sulfoximines and AlkynesThe Copper-Catalyzed OxidativeN-Acylation of SulfoximinesSynthesis of Sulfondiimines byN-Chlorosuccinimide-Mediated Oxidative Imination of Sulfiliminium SaltsPalladium-Catalyzed CN Cross-Coupling ofN′-Monosubstituted Sulfondiimines with Aryl BromidesSynthesis of N-Methyl-2-indolyl- and N-Methyl-2-benzo[b]furyl-Substituted Sulfoximines by Pd/Cu Co-Catalyzed Domino Cross-Coupling/Cyclization Reactions
P2860
Q36390162-6BCDE831-CF23-4257-B7E6-0AE80A4E9EFDQ36767926-690B370A-D7AB-486A-A1E7-642A7C55A866Q38128269-49CBB7A2-A2B5-4EB7-B9D2-3363E462457CQ39229336-0C269E34-F1A0-41A6-9905-054F3F8BD2EFQ41810226-3CCE7629-524A-4CC1-B782-A8C46F86CF3FQ47797785-D08D7EBA-AF38-41E6-87FA-12F87CEF2230Q48136672-7BE15233-0210-435F-9191-0D8EFB6ABDFAQ48364779-C622A173-D180-425F-B765-EDC5EE492912Q49790987-240A7B90-C13B-4094-846A-E1486C139435Q50048221-38D05D9A-9CB7-4B34-8763-8864B28BDDF9Q57404748-49A358DB-126F-4A2E-9F38-4321B1896719Q57404759-22FD6766-EFB2-4E63-948B-205C6AD5288FQ57404768-7B8EB8A2-6FD1-4490-98E5-31AA1575A126Q57404778-A6541865-57BA-4F35-8028-1A8BD0B903F5Q57404787-F14A5B81-FC81-4152-9262-337D78EB32EAQ57404797-65955D7A-C391-4B40-98AF-523C3B4C9B9FQ57404803-E64EE451-6D32-495E-8675-E0E66FBCC2D6Q57404810-C925A6E9-9125-41E4-A70B-9CF3B1F1CAB6
P2860
Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@ast
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@en
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@nl
type
label
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@ast
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@en
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@nl
prefLabel
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@ast
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@en
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@nl
P2093
P1476
Sulfoximine-substituted triflu ...... K2) show reduced hERG activity
@en
P2093
Amy Baumann
Angel Guzman-Perez
Anil Mistry
Daniel P Walker
Daniel W Kung
Janet A Houser
Jason Boer
Jian-Cheng Li
Leonard Buckbinder
P304
P356
10.1016/J.BMCL.2009.04.093
P407
P577
2009-06-15T00:00:00Z